UK markets close in 7 hours 27 minutes

Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
407.15+30.89 (+8.21%)
At close: 04:00PM EDT
413.69 +6.54 (+1.61%)
After hours: 07:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.61B
Enterprise value 12.34B
Trailing P/E 41.50
Forward P/E 38.02
PEG ratio (5-yr expected) 2.77
Price/sales (ttm)6.60
Price/book (mrq)18.78
Enterprise value/revenue 6.55
Enterprise value/EBITDA 33.99

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 399.65%
S&P500 52-week change 325.01%
52-week high 3419.42
52-week low 3189.30
50-day moving average 3395.53
200-day moving average 3301.45

Share statistics

Avg vol (3-month) 3271.11k
Avg vol (10-day) 3267.31k
Shares outstanding 530.98M
Implied shares outstanding 630.98M
Float 825.28M
% held by insiders 118.16%
% held by institutions 181.94%
Shares short (28 Mar 2024) 4946.6k
Short ratio (28 Mar 2024) 43.62
Short % of float (28 Mar 2024) 44.59%
Short % of shares outstanding (28 Mar 2024) 43.06%
Shares short (prior month 29 Feb 2024) 4937.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 15.92%
Operating margin (ttm)20.36%

Management effectiveness

Return on assets (ttm)13.89%
Return on equity (ttm)61.35%

Income statement

Revenue (ttm)1.96B
Revenue per share (ttm)63.97
Quarterly revenue growth (yoy)17.70%
Gross profit (ttm)N/A
EBITDA 382.05M
Net income avi to common (ttm)312.32M
Diluted EPS (ttm)9.81
Quarterly earnings growth (yoy)40.70%

Balance sheet

Total cash (mrq)407.01M
Total cash per share (mrq)13.17
Total debt (mrq)136.16M
Total debt/equity (mrq)20.27%
Current ratio (mrq)0.78
Book value per share (mrq)21.72

Cash flow statement

Operating cash flow (ttm)505.98M
Levered free cash flow (ttm)427.6M